003020 立方制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资169,6243.46%163,95114,39820,7080
投资性房地产25,224-1.53%25,6172,6713,0913,511
固定资产587,73437.56%427,255182,376141,888132,568
在建工程333,441-27.46%459,661340,893130,34966,465
无形资产109,004-3.78%113,28583,38289,50831,420
商誉74,4410.00%74,441000
其他非流动资产93,24036.47%68,32345,12969,25310,094
1,392,7084.52%1,332,533668,850454,797244,058

流动资产
货币资金267,767-46.76%502,929642,580654,254766,586
应收账款354,61137.21%258,447320,921282,657235,059
存货220,410-9.26%242,914361,765188,857193,800
其他流动资产248,40969.15%146,856127,28193,88096,517
1,091,197-5.21%1,151,1471,452,5471,219,6481,291,961

流动负债
短期借款0--0000
应付票据0--0213,72093,677161,841
应付帐款340,43613.01%301,251246,935149,252118,438
其他流动负债198,145-17.95%241,479161,97385,12562,070
538,581-0.76%542,729622,628328,054342,348
流动资产净值552,616-9.17%608,417829,919891,594949,613
资产总额减流动负债1,945,3240.23%1,940,9501,498,7691,346,3911,193,671

非流动负债
长期借款31,0260.04%31,014000
应付债券0--0000
其他非流动负债35,353-2.98%36,43818,90742,48019,678
66,379-1.59%67,45218,90742,48019,678

总权益
    实收股本191,57219.98%159,675122,46792,64092,640
    储备项目1,500,835-1.64%1,525,8511,357,3951,211,2711,081,353
股东权益1,692,4060.41%1,685,5261,479,8621,303,9111,173,993
非控股权益186,538-0.76%187,972000